| Literature DB >> 31975288 |
Justin Avery Aunger1,2, Colin J Greaves3,4, Edward T Davis3,5, Evans Atiah Asamane3,6, Anna C Whittaker3,7, Carolyn Anne Greig3,4,8.
Abstract
BACKGROUND: Osteoarthritis is a prevalent condition in older adults that causes many patients to require a hip or knee replacement. Reducing patients' sedentariness prior to surgery may improve physical function and post-operative outcomes.Entities:
Keywords: Behaviour change; Intervention; Older adults; Osteoarthritis; Prehabilitation; Sedentary
Mesh:
Year: 2020 PMID: 31975288 PMCID: PMC7680324 DOI: 10.1007/s40520-020-01475-6
Source DB: PubMed Journal: Aging Clin Exp Res ISSN: 1594-0667 Impact factor: 3.636
Standard Protocol Items Recommendations for Interventional Trials (SPIRIT) diagram to show the participant schedule, including enrolment, allocation, data collection visit (T1–3), intervention visit (IV), and assessments [55]
| Study period | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Recruitment | Baseline | Allocation | Post-allocation | Close-out | |||||||
| Type of contact | Pre-enrolment | Visit 1 (T1) | Allocation | Visit 2 (IV1) | Visit 3 (IV2) | PC 1 | PC 2 | PC 3 | Visit 4 (T2) | Visit 5 (T3) | Post-study |
| Timepoint (weeks) | 1 | 2 | 3 | 3 | 3 | 5 | 7 | 9 | 1 week prior to surgery | 6 weeks post-surgery | |
| Study member | Research nurse | R | Third party | R | R | R | R | R | R | R | R |
| Enrolment | |||||||||||
| Eligibility screening | |||||||||||
| Informed consent | × | ||||||||||
| Allocation | × | ||||||||||
| Study groups | |||||||||||
| Sedentary behaviour reduction | × | × | × | × | × | × | × | × | × | × | |
| Regular care | × | × | × | × | × | ||||||
| Assessments | |||||||||||
| Feasibility (study statistics) | × | ||||||||||
| Feasibility (interviews with research nurses) | × | ||||||||||
| Feasibility (questionnaire) | × | × | |||||||||
| Socio-demographics | × | ||||||||||
| ActivPal measurements | × | × | × | ||||||||
| IPAQ-SF [ | × | × | |||||||||
| MOST [ | × | × | × | ||||||||
| Quality of life (QoL) (EuroQoL 5D-5L, EuroQoL-Visual-analogue scale) [ | × | × | × | ||||||||
| Oxford hip and knee score(s) [ | × | × | × | ||||||||
| BPNS [ | × | × | × | ||||||||
| Activities of daily living (ADL) (Katz-ADL) [ | × | × | |||||||||
| SPPB [ | × | × | × | ||||||||
| SF-MNA [ | × | ||||||||||
| Weight | × | × | × | ||||||||
| Height | × | ||||||||||
| Waist-to-hip ratio | × | × | |||||||||
| Cardiometabolic biomarkers | × | × | |||||||||
R researcher, PC phone call, CRP C-reactive protein
Within and between-group changes from baseline (T1) to pre-surgery (T2)
| Outcome | Intervention | Usual care | Mean difference in changes between groups | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baselinea | Pre-surgerya | Mean difference (95% CI) | Baselinea | Pre-surgerya | Mean difference (95% CI) | Mean difference (95% CI)c | Effect size (Klauer’s | |||
| BMIb | 21 | 30.1 (3.77) | 29.66 (4.01) | − 0.44 (1.65, 0.77) | 8 | 31.07 (3.57) | 30.03 (3.93) | − 1.04 (− 3.50 to 1.41) | 0.60 (− 1.73 to 2.93) | 0.16 |
| Waist-to-hip ratiob | 21 | 0.91 (0.10) | 0.89 (0.10) | − 0.02 (− 0.05, 0.01) | 8 | 0.88 (0.09) | 0.90 (0.09) | 0.02 (− 0.01, 0.04) | − 0.03 (− 0.08, 0.02) | − 0.36 |
| SPPB total points (0–12) | 21 | 6.95 (3.09) | 7.67 (2.97) | 0.71 (0.07, 1.36) | 8 | 6.75 (2.31) | 7.13 (2.70) | 0.38 (− 0.88, 1.63) | 0.34 (− 0.89, 1.57) | 0.11 |
| MOST Total (min.d−1) | 21 | 479.66 (141.00) | 463.31 (182.53) | − 16.35 (− 107.48, 74.78) | 9 | 623.65 (186.17) | 502.14 (179.70) | − 121.51 (− 251.56, 8.55) | 105.16 (− 51.42, 261.73) | 0.71 |
| Sedentary time (min.d−1) | 19 | 607.49 (132.62) | 575.23 (84.27) | − 31.26 (− 87.42, 24.89) | 6 | 557.28 (83.01) | 562.08 (112.89) | 4.80 (− 90.42, 100.02) | − 36.06 (− 144.00, 71.87) | − 0.25 |
| Upright time (min.d−1) | 19 | 322.06 (117.22) | 327.89 (120.59) | 5.83 (− 25.15, 36.81) | 6 | 326.90 (105.63) | 338.13 (135.87) | 11.22 (− 42.37, 64.82) | − 5.40 (− 65.11, 54.32) | − 0.04 |
| Sleeping time (min.d−1) | 19 | 509.74 (112.39) | 511.15 (117.91) | 1.42 (− 39.52, 42.35) | 6 | 550.78 (76.37) | 495.26 (79.51) | − 55.52 (− 159.51, 48.48) | 56.93 (− 28.51, 142.38) | 0.53 |
| Steps per day | 19 | 4949.26 (3732.46) | 5060.05 (3967.73) | 110.79 (− 591.39, 812.97) | 6 | 3811.17 (617.63) | 3743.17 (1422.46) | − 68.00 (− 1560.67, 1424.67) | 178.79 (− 1225.32, 1582.90) | 0.03 |
| Time spent in sedentary bouts > 30 (min.d−1) | 19 | 314.20 (164.69) | 310.68 (127.27) | − 3.52 (− 74.51, 67.46) | 6 | 350.89 (103.67) | 331.41 (107.14) | − 19.49 (− 108.22, 69.25) | 15.96 (− 115.90, 147.83) | 0.07 |
| Time spent in sedentary bouts > 60 (min.d−1) | 19 | 173.44 (154.82) | 173.38 (85.83) | − 0.07 (− 69.14, 69.00) | 6 | 232.00 (101.49) | 199.59 (96.70) | − 32.41 (− 91.56, 26.74) | 32.35 (− 93.07, 157.77) | 0.11 |
| Sit-to-stand transitions | 19 | 41.95 (17.28) | 37.95 (11.57) | − 4.00 (− 9.10, 1.10) | 6 | 33.33 (11.72) | 34.17 (9.22) | 0.83 (− 6.95, 8.61) | − 4.83 (− 14.50, 4.83) | − 0.19 |
| Oxford Hip/Knee Score (0–48) | 21 | 20.52 (7.69) | 22.67 (8.56) | 2.14 (− 1.11, 5.39) | 8 | 18.00 (9.83) | 19.50 (9.46) | 1.50 (− 4.38, 7.38) | 0.64 (− 5.42, 6.70) | 0.06 |
| EQ-5D-5L Mobility (1–5) | 21 | 1.86 (1.01) | 2.91 (1.00) | 1.05 (0.43, 1.67)** | 9 | 1.67 (1.12) | 3.22 (0.67) | 1.56 (0.40, 2.72)** | − 0.51 (− 1.65, 0.64) | − 0.53 |
| EQ-5D-5L Pain (1–5) | 21 | 2.00 (1.30) | 3.33 (0.91) | 1.33 (0.58, 2.09)** | 9 | 2.11 (1.27) | 3.33 (1.00) | 1.22 (− 1.0, 2.54)** | 0.11 (− 1.25, 1.48) | 0.09 |
| EQ-5D-5L anxiety (1–5) | 21 | 3.14 (1.24) | 1.38 (0.59) | − 1.76 (− 2.34, − 1.19)** | 9 | 3.33 (1.33) | 2.22 (1.30) | − 1.11 (− 2.16, − 0.06)** | − 0.65 (− 1.71, 0.40) | − 0.83 |
| EQ-VAS (0–100) | 21 | 67.57 (21.14) | 72.86 (17.36) | 5.29 (− 4.97, 15.54) | 9 | 60.56 (18.78) | 59.44 (13.57) | − 1.11 (− 11.94, 9.72) | 6.40 (− 10.32, 23.11) | 0.48 |
| BPNS autonomy score (0–7) b | 21 | 5.91 (0.96) | 6.07 (0.74) | 0.16 (− 0.26, 0.58) | 9 | 4.89 (1.12) | 5.18 (1.32) | 0.29 (− 1.02, 1.60) | − 0.13 (− 1.11, 0.84) | − 0.07 |
| BPNS competence score (0–7) b | 21 | 4.64 (1.13) | 4.67 (0.96) | 0.03 (− 0.51, 0.57) | 9 | 4.13 (1.12) | 4.13 (1.16) | 0.00 (− 0.86, 0.86) | 0.03 (− 0.93, 0.98) | 0.07 |
| BPNS relatedness score (0–7) b | 21 | 6.16 (0.90) | 6.16 (0.74) | 0.00 (− 0.43, 0.44) | 9 | 5.86 (0.62) | 5.71 (1.17) | − 0.15 (− 0.86, 0.56) | 0.16 (− 0.62, 0.93) | 0.16 |
| Cholesterol (mmol/L) b | 14 | 4.36 (0.91) | 4.29 (0.92) | − 0.07 (− 0.41, 0.27) | 6 | 4.82 (1.42) | 4.38 (0.89) | − 0.43 (− 1.46, 0.59) | 0.36 (− 0.37, 1.09) | 0.32 |
| HDL (mmol/L) | 14 | 1.39 (0.36) | 1.47 (0.39) | 0.07 (− 0.04, 0.19) | 6 | 1.51 (0.37) | 1.48 (0.42) | − 0.02 (− 0.23, 0.18) | 0.10 (− 0.10, 0.30) | 0.27 |
| LDL (mmol/L) | 14 | 2.31 (0.75) | 2.25 (0.77) | − 0.06 (− 0.26, 0.14) | 6 | 2.77 (1.35) | 2.28 (0.79) | − 0.49 (− 1.36, 0.38) | 0.43 (− 0.44, 1.30) | 0.44 |
| Triglycerides (mmol/L)b | 14 | 1.46 (0.79) | 1.26 (0.57) | − 0.19 (− 0.58, 0.19) | 6 | 1.20 (0.32) | 1.37 (0.44) | 0.17 (− 0.12, 0.45) | − 0.36 (− 0.96, 0.24) | − 0.57 |
| HBA1c (mmol/L) | 16 | 39.13 (8.57) | 39.44 (8.40) | 0.31 (− 0.46, 1.08) | 5 | 39.40 (1.82) | 39.40 (1.14) | 0.00 (− 2.91, 2.91) | 0.31 (− 1.49, 2.11) | 0.04 |
| Cortisol (mmol/L) | 13 | 334.38 (131.23) | 374.62 (77.08) | 40.23 (− 35.39, 115.85) | 3 | 315.00 (22.52) | 526.00 (239.90) | 211.00 (− 435.21, 857.21) | − 170.77 (− 379.52, 37.98) | − 1.47 |
| DHEAS (mmol/L) | 13 | 1.36 (0.77) | 1.30 (0.72) | − 0.06 (− 0.25, 0.13) | 4 | 1.71 (1.18) | 1.71 (1.08) | 0.00 (− 0.61, 0.60) | − 0.06 (− 0.45, 0.34) | − 0.10 |
aValues are mean (SD)
bShapiro–Wilk test indicated that these data were not normal in one or both groups (p ≤ 0.05), so within-group p values reported here are from Wilcoxon signed-rank or sign rank tests
cCalculated as “[Intervention Mean Difference T1 to T2]—[Usual Care Mean Difference T1 to T2]”
**p < 0.001
Fig. 1Consort 2010 participant flow diagram [33]
Baseline characteristics of sample
| Variable | Intervention ( | Usual care ( | Total ( |
|---|---|---|---|
| Age | 73.25 (5.55) | 72.91 (6.54) | 73.14 (5.78) |
| School years | 11.5 (2.27) | 11.36 (1.5) | 11.46 (2.03) |
| Weight (kg) | 83.89 (12.82) | 83.29 (16.46) | 83.70 (13.82) |
| Medical conditions | 3.13 (1.48) | 3.73 (1.74) | 3.31 (1.57) |
| BMI (kg/m2) | 31.00 (4.36) | 30.03 (3.76) | 30.70 (4.15) |
| Waist-to-hip ratio | 0.92 (0.11) | 0.92 (0.13) | 0.92 (0.11) |
| Katz ADL (0–6) | 5.62 (0.71) | 5.00 (1.18) | 5.43 (0.92) |
| MNA-SF (0–14) | 12.08 (2.36) | 12.27 (1.9) | 12.14 (2.20) |
| Surgery type | |||
| Knee | 13 (54.2) | 5 (45.5) | 18 (51.4) |
| Hip | 11 (45.8) | 6 (54.5) | 17 (48.6) |
| Sex | |||
| Men | 10 (41.7) | 5 (45.5) | 15 (42.9) |
| Women | 14 (58.3) | 6 (54.5) | 20 (57.1) |
| Marital status | |||
| Married | 15 (62.5) | 10 (90.9) | 25 (71.4) |
| Separated | 4 (16.7) | 1 (9.1) | 5 (14.3) |
| Widowed | 5 (20.8) | 0 (0) | 5 (14.3) |
| Education | |||
| Primary | 0 (0) | 1 (9.10) | 1 (2.9) |
| Secondary | 18 (75.00) | 8 (72.7) | 26 (74.3) |
| University | 5 (20.8) | 2 (18.2) | 7 (20.0) |
| Post-graduate | 1 (4.2) | 0 (0) | 1 (2.9) |
| Living status | |||
| Alone | 7 (29.2) | 2 (18.2) | 9 (25.7) |
| Not alone | 17 (70.8) | 9 (81.8) | 26 (74.3) |
| Housing type | |||
| Privately owned | 21 (87.5) | 10 (90.9) | 31 (88.6) |
| Family owned | 1 (4.2) | 0 (0) | 1 (2.9) |
| Public rental | 2 (8.3) | 0 (0) | 1 (2.9) |
| Sheltered housing | 0 (0) | 1 (0) | 2 (5.7) |
| Pets | |||
| No pets | 16 (66.7) | 6 (54.5) | 22 (62.9) |
| Dog(s) | 2 (8.3) | 2 (18.2) | 4 (11.4) |
| Other pet(s) | 6 (25) | 3 (27.3) | 9 (25.7) |
| Currently drinking alcohol | |||
| Yes | 13 (54.2) | 5 (45.5) | 19 (54.3) |
| No | 11 (45.8) | 6 (54.5) | 16 (45.7) |
| Smoking | |||
| Yes | 1 (4.2) | 0 (0) | 1 (2.9) |
| No | 23 (95.8) | 11 (100) | 34 (97.1) |
| Former smoking | |||
| Yes | 9 (37.5) | 6 (54.5) | 15 (42.9) |
| No | 15 (62.5) | 5 (45.5) | 20 (57.1) |
| SPPB total points | 6.92 (2.95) | 7.00 (2.45) | 6.94 (2.77) |
| BPNS autonomy | 5.88 (0.94) | 5.04 (1.07) | 5.61 (1.04) |
| BPNS competence | 4.63 (1.08) | 4.18 (1.01) | 4.49 (1.06) |
| BPNS relatedness | 6.10 (0.92) | 5.93 (0.67) | 6.05 (0.85) |
| Oxford joint score | 20.29 (7.85) | 19.27 (8.71) | 19.97 (8.01) |
| MOST total time (min.d−1) | 485.42 (135.37) | 631.04 (210.92) | 531.18 (173.74) |
| Mean sedentary time (min.d−1)a | 607.51 (125.13) | 552.06 (72.21) | 590.18 (113.91) |
| Mean upright time (min.d−1)a | 327.25 (80.16) | 333.8 (116.81) | 329.29 (104.44) |
| Mean steps per daya | 5170 (3603) | 4907 (2978) | 5088.25 (3374.1) |
| Mean sit-to-stand transitionsa | 41.05 (16.29) | 35.95 (13.18) | 39.45 (15.36) |
| Time spent in sitting bouts > 30 min (min.d−1)a | 314.09 (165.4) | 324.16 (86.88) | 317.18 (144.03) |
| Time spent in sitting bouts > 60 min (min.d−1)a | 173.24 (153.26) | 179.20 (104.48) | 175.10 (138.16) |
Data are mean (SD) or N (%). ActivPal3 measures indicated with a are from n = 22 in the intervention group and n = 10 in the usual care group (n = 32 in total)
Feasibility
Feasibility—(study statistics)
Overall feasibility statistics
| Statistic | Value |
|---|---|
| Study uptake rate | 14.2% (95% CI; 10.2%, 19.4%) |
| Recruitment rate | 3.0 (2.6) participants per month |
| Intervention adherence | Goal data completion: 55.8% Environmental modification completion: 16.7% Mean goal adherence (where complete): 3.9 (0.7) out of 5 Mean environmental modification adherence (where complete): 4.2 (0.7) out of 5 |
| Percentage of participants whose surgery occurred 8 or more weeks after visit 3 (IV2) (or visit 1 in usual care) | 66.7% |
| Percentage of participants whose surgery was scheduled 4 or fewer weeks after visit 3 (or visit 1 in usual care) | 16.7% |
| Percentage of participants with indefinitely delayed or cancelled surgery | 31.4% |
| Retention rates | 85.7% (95% CI; 69.0%, 94.6%) at T2, 48.6% (95% CI; 31.7%, 65.7%) at T3 |
| Mean duration of intervention | Intervention: 8.5 weeks [59.8 (8.5) days] Usual Care: 16.5 weeks [115.2 (68.2) days] |
| Session attendance | 100% |
Data are mean (SD), or %
Fig. 2Step count targets set during intervention, versus mean daily step counts measured at pre-surgery (T2)
Summary of criteria for progression to a definitive trial
| Criterion | Assessment | Conclusion |
|---|---|---|
| A minimum of 75% of patients had their surgeries within 10 days of the 4–8-week intervention window between visit 1 (usual care) or visit 3 (intervention), and pre-surgery (visit 4 or T2) | 36.67% ( | This aspect was not feasible |
| Rate of uptake meets or exceeds 10% | The rate of uptake was 14.2% | This aspect was feasible |
| Participant retention rate exceeds 75% between baseline and pre-surgery visits | The retention rate at pre-surgery (T2) was 85.7% | This aspect was feasible |
| Study satisfaction must be ≥ 4/5, and risk of harm should be < 2/5, as assessed by the feasibility questionnaire given to participants | All these criteria were met at both T2 and T3. Overall mean satisfaction for both groups was 4.75. Risk of harm was assessed no higher than 1 by any participant | This aspect was feasible |
| The frequency of adverse events does not call into question the safety of the trial as determined by the medical expert on the study (ETD) | One adverse event occurred. This was classified as a serious adverse event, but it was not related to the study | This aspect was feasible |
Fig. 3Plots of individual changes in short physical performance battery (SPPB) in each group, as well as sedentary time, from T1 to T2. For SPPB, positive change is better, and for sedentary time, negative change is preferred
Fig. 4Changes over time in variables assessed within this section. Error bars are standard error. SPPB short physical performance battery, BPNS basic psychological needs in general scale
Change in outcomes from baseline through post-surgery in participants retained to end of study
| Outcome | Group | Baseline | Pre-surgery | Post-surgery | |
|---|---|---|---|---|---|
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |||
| Total SPPB points (0–12) | Intervention | 12 | 7.75 (5.90, 9.60) | 8.33 (6.54, 10.13) | 9.33 (7.89, 10.78) |
| Usual care | 5 | 6.4 (3.54, 9.26) | 6.8 (4.02, 9.58) | 8.0 (5.76, 10.24) | |
| Sedentary time (min.d−1) | Intervention | 8 | 623.85 (519.83, 727.88) | 557.84 (475.36, 640.31) | 594.31 (503.26, 685.36) |
| Usual care | 4 | 555.75 (408.64, 702.86) | 576.48 (459.85, 693.12) | 644.16 (515.40, 772.93) | |
| Upright time (min.d−1) | Intervention | 8 | 302.18 (197.54, 406.81) | 328.65 (212.70, 444.61) | 270.82 (167.61, 374.03) |
| Usual care | 4 | 332.91 (184.94, 480.89) | 331.79 (167.81, 495.77) | 315.62 (169.66, 461.57) | |
| Steps per day ( | Intervention | 8 | 3462.00 (2541.71, 4382.29) | 4138.75 (2930.16, 5347.34) | 3720.13 (2466.69, 4973.56) |
| Usual care | 4 | 3730.00 (2428.52, 5031.48) | 3732.50 (2023.29, 5441.71) | 2935.75 (1163.13, 4708.37) | |
| BPNS autonomy (0–7) | Intervention | 12 | 6.26 (5.72, 6.80) | 6.25 (5.82, 6.68) | 6.26 (5.92, 6.60) |
| Usual care | 5 | 4.34 (3.51, 5.18) | 5.57 (4.91, 6.24) | 5.34 (4.82, 5.87) | |
| Oxford (hip or knee) score (0–48) | Intervention | 12 | 21.75 (16.74, 26.76) | 22.33 (17.37, 27.30) | 33.67 (29.67, 37.66) |
| Usual care | 5 | 14.40 (6.64, 22.16) | 18.80 (11.11, 26.50) | 30.60 (24.41, 36.79) |
Fig. 5INTEREST logic model with areas assessed by an outcome measure indicated in blue, and those unassessed indicated in red. Bold, italic text indicates the outcome measure used to measure the attached outcome or assumption